Recent News

• 01.12.2026 - Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
• 11.12.2025 - Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress

Recent Filings

• 01.14.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.14.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.12.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 01.12.2026 - 144 Report of proposed sale of securities
• 01.02.2026 - 8-K Current report
• 12.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.17.2025 - 144 Report of proposed sale of securities